Lidocaine injectable

Lidocaine injectable

Form: Injectable

Strength: 1%, 2%, 5%

Reference Brands: Xylocaine, Lidocaine Plus(US)

Category: Analgesic

Lidocaine injectable is approved in the EU and US for local anesthesia and pain management in surgical and diagnostic procedures. In the EU, brands like Xylocaine are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data and adherence to manufacturing standards, with strict pharmacovigilance. Both regions enforce rigorous controls due to the risk of misuse and toxicity. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for lidocaine injectables, ensuring adherence to European and American standards for safe, effective anesthetic use while navigating complex regulatory landscapes seamlessly.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Dexketoprofen + Tramadol tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details Get Enquiry
Paracetamol + Codeine tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details Get Enquiry
Aceclofenac + Paracetamol tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry
Tramadol + Paracetamol tablets

Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg

Form: Oral Tablets

Reference Brands: Ultracet(US); Tramacet(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.